BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 27688479)

  • 1.
    Whitwell JL; Graff-Radford J; Singh TD; Drubach DA; Senjem ML; Spychalla AJ; Tosakulwong N; Lowe VJ; Josephs KA
    J Nucl Med; 2017 Apr; 58(4):632-638. PubMed ID: 27688479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET.
    Nedelska Z; Senjem ML; Przybelski SA; Lesnick TG; Lowe VJ; Boeve BF; Arani A; Vemuri P; Graff-Radford J; Ferman TJ; Jones DT; Savica R; Knopman DS; Petersen RC; Jack CR; Kantarci K
    Neuroimage Clin; 2018; 19():939-947. PubMed ID: 30003031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.
    Iizuka T; Kameyama M
    Ann Nucl Med; 2016 Jul; 30(6):421-9. PubMed ID: 27098829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.
    Lim SM; Katsifis A; Villemagne VL; Best R; Jones G; Saling M; Bradshaw J; Merory J; Woodward M; Hopwood M; Rowe CC
    J Nucl Med; 2009 Oct; 50(10):1638-45. PubMed ID: 19759102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amygdala sign, a FDG-PET signature of dementia with Lewy Bodies.
    Pillai JA; Wu G; Tousi B; Larvie M; Léger GC; Leverenz JB
    Parkinsonism Relat Disord; 2019 Jul; 64():300-303. PubMed ID: 30905401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
    Spehl TS; Hellwig S; Amtage F; Weiller C; Bormann T; Weber WA; Hüll M; Meyer PT; Frings L
    J Neuroimaging; 2015; 25(2):281-288. PubMed ID: 24593796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain
    Woyk K; Sahlmann CO; Hansen N; Timäus C; Müller SJ; Khadhraoui E; Wiltfang J; Lange C; Bouter C
    J Neuroimaging; 2023 Mar; 33(2):256-268. PubMed ID: 36465027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse occipital hypometabolism on [18 F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with Lewy bodies?
    Fujishiro H; Iseki E; Murayama N; Yamamoto R; Higashi S; Kasanuki K; Suzuki M; Arai H; Sato K
    Psychogeriatrics; 2010 Sep; 10(3):144-52. PubMed ID: 20860570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies.
    Chiba Y; Fujishiro H; Iseki E; Kasanuki K; Sato K
    J Neuroimaging; 2019 Nov; 29(6):712-720. PubMed ID: 31199036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD.
    Kantarci K; Boeve BF; Przybelski SA; Lesnick TG; Chen Q; Fields J; Schwarz CG; Senjem ML; Gunte JL; Jack CR; Min P; Jain M; Miyagawa T; Savica R; Graff-Radford J; Botha H; Jones DT; Knopman DS; Graff-Radford N; Ferman TJ; Petersen RC; Lowe VJ
    Neuroimage Clin; 2021; 31():102754. PubMed ID: 34252877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A visual rating scale for cingulate island sign on 18F-FDG-PET to differentiate dementia with Lewy bodies and Alzheimer's disease.
    Gjerum L; Frederiksen KS; Henriksen OM; Law I; Anderberg L; Andersen BB; Bjerregaard E; Hejl AM; Høgh P; Hasselbalch SG
    J Neurol Sci; 2020 Mar; 410():116645. PubMed ID: 31911283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic imaging patterns in posterior cortical atrophy and Lewy body dementia.
    Gupta V; Verma R; Ranjan R; Belho ES; Seniaray N; Dinand V; Malik D; Mahajan H
    Nucl Med Commun; 2019 Dec; 40(12):1275-1282. PubMed ID: 31633646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria.
    Caminiti SP; Sala A; Iaccarino L; Beretta L; Pilotto A; Gianolli L; Iannaccone S; Magnani G; Padovani A; Ferini-Strambi L; Perani D
    Alzheimers Res Ther; 2019 Feb; 11(1):20. PubMed ID: 30797240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered structural and functional connectivity in Posterior Cortical Atrophy and Dementia with Lewy bodies.
    Singh NA; Goodrich AW; Graff-Radford J; Machulda MM; Sintini I; Carlos AF; Robinson CG; Reid RI; Lowe VJ; Jack CR; Petersen RC; Boeve BF; Josephs KA; Kantarci K; Whitwell JL
    Neuroimage; 2024 Apr; 290():120564. PubMed ID: 38442778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.
    Chiba Y; Fujishiro H; Ota K; Kasanuki K; Arai H; Hirayasu Y; Sato K; Iseki E
    Int J Geriatr Psychiatry; 2015 Mar; 30(3):316-23. PubMed ID: 24839913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial metabolic profiles to discriminate dementia with Lewy bodies from Alzheimer disease.
    Iizuka T; Kameyama M
    J Neurol; 2020 Jul; 267(7):1960-1969. PubMed ID: 32170446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
    Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
    Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dementia with Lewy bodies: basis of cingulate island sign.
    Graff-Radford J; Murray ME; Lowe VJ; Boeve BF; Ferman TJ; Przybelski SA; Lesnick TG; Senjem ML; Gunter JL; Smith GE; Knopman DS; Jack CR; Dickson DW; Petersen RC; Kantarci K
    Neurology; 2014 Aug; 83(9):801-9. PubMed ID: 25056580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating 2-[
    Gjerum L; Frederiksen KS; Henriksen OM; Law I; Bruun M; Simonsen AH; Mecocci P; Baroni M; Dottorini ME; Koikkalainen J; Lötjönen J; Hasselbalch SG
    Neuroimage Clin; 2020; 27():102267. PubMed ID: 32417727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, FDG and amyloid PET imaging in posterior cortical atrophy.
    Singh TD; Josephs KA; Machulda MM; Drubach DA; Apostolova LG; Lowe VJ; Whitwell JL
    J Neurol; 2015 Jun; 262(6):1483-92. PubMed ID: 25862483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.